Clinical Trial Update: Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency

View source ↗

Summary

A completed clinical trial investigating the causes of hypertension and endothelial damage in individuals with cytochrome P450 oxidoreductase deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia
• Cytochrome P450 Oxidoreductase Deficiency
• Endothelial Dysfunction
• Hypertension

Snippet

Sponsor: Ozge Bayrak Demirel | Conditions: Cytochrome P450 Oxidoreductase Deficiency, Hypertension | Status: COMPLETED